![Mark Sullivan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Sullivan
Fondatore presso Medicines Development for Global Health Ltd
Posizioni attive di Mark Sullivan
Società | Posizione | Inizio | Fine |
---|---|---|---|
Medicines Development for Global Health Ltd
![]() Medicines Development for Global Health Ltd Pharmaceuticals: MajorHealth Technology Medicines Development Ltd. engages in the development of medicines and vaccines. Its development programs include Moxidectin Program, Global Health Programs, and Consulting ervices. The company was founded by Mark Sullivan in 2005 and is headquartered in Melbourne, Australia. | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | 01/10/2005 | - | |
Fondatore | 01/10/2005 | - | |
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Investitore di Private Equity | 01/07/2020 | - |
Global Health Funds LLC | Consulente / Consigliere | 01/12/2020 | - |
Storia della carriera di Mark Sullivan
Precedenti posizioni note di Mark Sullivan
Società | Posizione | Inizio | Fine |
---|---|---|---|
OPTHEA LIMITED | Corporate Officer/Principal | 18/02/2011 | 15/12/2012 |
University of New South Wales Built Environment | Direttore operativo | 01/03/2003 | 30/09/2005 |
GILEAD SCIENCES, INC. | Direttore/Membro del Consiglio | 01/01/2001 | 31/12/2003 |
i3 Global
![]() i3 Global Miscellaneous Commercial ServicesCommercial Services i3 Global operates as a pharmaceutical services company. It offers therapeutically specialized contract research solutions, clinical data services, staffing solutions, pharmacovigilance and epidemiology solutions. The company was founded in 1988 and is headquartered in Bernards, NJ. | Direttore/Membro del Consiglio | 01/11/1999 | 31/12/2000 |
Formazione di Mark Sullivan
Deakin University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Australia | 5 |
Posizioni
Director/Board Member | 3 |
Corporate Officer/Principal | 1 |
Chief Executive Officer | 1 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
OPTHEA LIMITED | Health Technology |
Aziende private | 4 |
---|---|
i3 Global
![]() i3 Global Miscellaneous Commercial ServicesCommercial Services i3 Global operates as a pharmaceutical services company. It offers therapeutically specialized contract research solutions, clinical data services, staffing solutions, pharmacovigilance and epidemiology solutions. The company was founded in 1988 and is headquartered in Bernards, NJ. | Commercial Services |
Medicines Development for Global Health Ltd
![]() Medicines Development for Global Health Ltd Pharmaceuticals: MajorHealth Technology Medicines Development Ltd. engages in the development of medicines and vaccines. Its development programs include Moxidectin Program, Global Health Programs, and Consulting ervices. The company was founded by Mark Sullivan in 2005 and is headquartered in Melbourne, Australia. | Health Technology |
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Finance |
Global Health Funds LLC |
- Borsa valori
- Insiders
- Mark Sullivan
- Esperienza